See more : Médica Sur, S.A.B. de C.V. (MEDICAB.MX) Income Statement Analysis – Financial Results
Complete financial analysis of Hankook Cosmetics Co., Ltd. (123690.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hankook Cosmetics Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Zix Corporation (ZIXI) Income Statement Analysis – Financial Results
- Higher Way Electronic Co., Ltd. (3268.TWO) Income Statement Analysis – Financial Results
- Nordic American Tankers Limited (NAT) Income Statement Analysis – Financial Results
- Global Fashion Group S.A. (GLFGF) Income Statement Analysis – Financial Results
- Yamazen Corporation (8051.T) Income Statement Analysis – Financial Results
Hankook Cosmetics Co., Ltd. (123690.KS)
About Hankook Cosmetics Co., Ltd.
Hankook Cosmetics Co., Ltd. produces and sells cosmetics in South Korea and internationally. It offers its products under the Sansim, Hyoum, Ossion, Jutanhak, Secret Nature, Calli, GENERTE, A3F[on], Temptation, CONTINUE, Chess The Classic, CLASSYGIRL, Beautri, BEAUTENIQUE, Dr Medix, and Parapam brands. The company was founded in 1961 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 78.71B | 66.05B | 66.97B | 72.50B | 131.20B | 153.88B | 151.26B | 160.75B | 98.45B | 76.33B | 68.67B | 73.40B | 70.28B | 31.98B |
| Cost of Revenue | 38.42B | 33.42B | 31.38B | 33.99B | 58.47B | 70.18B | 67.28B | 71.65B | 40.62B | 33.18B | 28.51B | 29.91B | 25.13B | 12.03B |
| Gross Profit | 40.30B | 32.63B | 35.58B | 38.51B | 72.73B | 83.70B | 83.98B | 89.10B | 57.82B | 43.16B | 40.16B | 43.49B | 45.16B | 19.95B |
| Gross Profit Ratio | 51.19% | 49.41% | 53.14% | 53.11% | 55.43% | 54.39% | 55.52% | 55.43% | 58.73% | 56.54% | 58.48% | 59.25% | 64.25% | 62.38% |
| Research & Development | 108.76M | 96.35M | 108.63M | 46.42M | 141.36M | 600.08M | 636.26M | 677.83M | 538.80M | 609.73M | 714.58M | 599.82M | 543.68M | 325.40M |
| General & Administrative | 1.48B | 994.16M | 832.83M | 1.06B | 1.88B | 2.15B | 2.60B | 2.93B | 3.13B | 2.63B | 2.60B | 3.45B | 3.67B | 1.46B |
| Selling & Marketing | 22.73B | 18.37B | 22.38B | 33.21B | 55.37B | 61.18B | 50.88B | 48.32B | 42.06B | 32.84B | 31.41B | 35.47B | 38.24B | 14.68B |
| SG&A | 34.81B | 19.37B | 23.21B | 34.27B | 57.25B | 63.33B | 53.48B | 51.25B | 45.19B | 35.48B | 34.01B | 38.92B | 41.90B | 16.13B |
| Other Expenses | 0.00 | 13.19B | 15.46B | 21.18B | 32.73B | 227.62M | -416.24M | 268.25M | 46.09M | -3.00B | -381.91M | -178.54M | 18.73B | 440.91M |
| Operating Expenses | 34.87B | 32.65B | 38.78B | 55.50B | 90.12B | 91.19B | 76.39B | 73.40B | 63.28B | 54.05B | 53.26B | 60.12B | 61.18B | 23.97B |
| Cost & Expenses | 73.28B | 66.07B | 70.16B | 89.49B | 148.59B | 161.37B | 143.67B | 145.05B | 103.90B | 87.23B | 81.78B | 90.03B | 86.31B | 36.00B |
| Interest Income | 434.96M | 267.76M | 323.82M | 402.28M | 399.20M | 268.87M | 293.69M | 301.18M | 449.69M | 529.73M | 372.65M | 690.72M | 764.95M | 879.52M |
| Interest Expense | 251.23M | 379.35M | 561.12M | 604.47M | 555.99M | 260.11M | 38.39M | 0.00 | 0.00 | 1.73B | 2.47B | 2.26B | 1.26B | 111.98M |
| Depreciation & Amortization | 2.12B | 3.43B | 5.25B | 6.62B | 7.71B | 5.16B | 4.72B | 3.83B | 3.36B | 2.95B | 3.12B | 3.01B | 2.42B | 772.14M |
| EBITDA | 5.68B | 1.92B | 1.70B | 118.11M | -10.79B | -2.32B | 12.14B | 19.52B | -2.10B | -7.94B | -10.59B | -14.66B | -12.74B | -24.48B |
| EBITDA Ratio | 7.21% | 5.71% | 3.70% | -14.24% | -6.60% | -1.01% | 7.91% | 12.43% | -0.29% | -13.38% | -14.53% | -17.95% | -18.17% | -46.79% |
| Operating Income | 5.43B | 342.13M | -2.77B | -16.99B | -17.39B | -7.49B | 7.59B | 15.71B | -5.46B | -10.89B | -13.11B | -16.63B | -16.19B | -4.02B |
| Operating Income Ratio | 6.90% | 0.52% | -4.14% | -23.44% | -13.26% | -4.86% | 5.02% | 9.77% | -5.54% | -14.27% | -19.09% | -22.66% | -23.04% | -12.55% |
| Total Other Income/Expenses | -2.13B | -1.86B | -1.34B | 2.69B | -1.66B | -259.01M | -464.58M | 206.34M | -1.26B | 49.18B | -3.07B | -3.30B | -221.47M | -13.19B |
| Income Before Tax | 3.30B | -1.89B | -4.12B | -7.11B | -19.05B | -7.74B | 6.92B | 15.91B | -6.72B | 38.29B | -16.18B | -19.94B | -16.41B | -17.20B |
| Income Before Tax Ratio | 4.19% | -2.86% | -6.15% | -9.80% | -14.52% | -5.03% | 4.58% | 9.90% | -6.82% | 50.16% | -23.56% | -27.16% | -23.35% | -53.79% |
| Income Tax Expense | -246.32M | -2.31B | 3.16B | 466.40M | -1.83B | 1.68M | 2.89B | 1.30B | 2.34B | 11.96B | 12.40M | 442.82M | 837.65M | -11.72B |
| Net Income | 3.51B | 418.12M | -7.28B | -7.57B | -17.22B | -7.75B | 4.03B | 14.62B | -9.06B | 26.33B | -16.18B | -19.94B | -16.41B | -17.20B |
| Net Income Ratio | 4.46% | 0.63% | -10.87% | -10.45% | -13.13% | -5.03% | 2.66% | 9.09% | -9.20% | 34.50% | -23.56% | -27.16% | -23.35% | -53.79% |
| EPS | 218.00 | 26.02 | -453.20 | -471.39 | -1.07K | -482.11 | 251.00 | 910.00 | -564.00 | 1.64K | -1.01K | -1.24K | -1.02K | -1.07K |
| EPS Diluted | 218.48 | 26.02 | -453.20 | -471.39 | -1.07K | -482.00 | 251.00 | 910.00 | -564.00 | 1.64K | -1.01K | -1.24K | -1.02K | -1.07K |
| Weighted Avg Shares Out | 16.10M | 16.07M | 16.07M | 16.07M | 16.07M | 16.07M | 16.05M | 16.06M | 16.06M | 16.07M | 16.06M | 16.06M | 16.07M | 16.06M |
| Weighted Avg Shares Out (Dil) | 16.07M | 16.07M | 16.07M | 16.07M | 16.07M | 16.07M | 16.05M | 16.06M | 16.06M | 16.07M | 16.06M | 16.06M | 16.07M | 16.06M |
Source: https://incomestatements.info
Category: Stock Reports